Related Experiment Video
Updated: Apr 2, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Elevated microRNA-25 inhibits cell apoptosis in lung cancer by targeting RGS3
Zhize Chen1, Yang Wu2, Qingtao Meng2
1Department of Anesthesiology, Renmin Hospital, Wuhan University, Wuhan, 430060, Hubei, People's Republic of China. chzz668899@163.com.
Abstract:
The non-small-cell lung cancer (NSCLC) is the most common type of lung cancer that affects the human health. But, the underlying mechanisms and effective therapy are still absent. MicroRNAs (miRNAs) are small RNAs that specifically bind to the 3' untranslated region (3'UTR) of its target and regulate the protein level of the target at post-transcriptional level. A lot of miRNAs had been found abnormally regulated in the NSCLC patients, and understanding their specific roles in the pathogenesis of NSCLC will help us to develop novel therapeutic approaches. Here, we reported that miR-25 is dramatically upregulated in NSCLC tissues and negatively correlated with RGS3 protein. A conserved binding sequence in the 3'UTR of RGS3 gene to miR-25 was identified, and overexpression of miR-25 induces the RGS3 inhibition. Importantly, suppression of miR-25 facilitates the cell apoptosis and retards the cell proliferation in A549 and H520 cell lines. Our data provide a novel miR-25/RGS3 signal in the development of lung cancer.
Insights
MicroRNA-25 (miR-25) is elevated in non-small-cell lung cancer (NSCLC), inhibiting RGS3 protein. Suppressing miR-25 halts NSCLC cell growth and promotes apoptosis.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide.
- Effective therapeutic strategies for NSCLC are limited due to incomplete understanding of its underlying molecular mechanisms.
- MicroRNAs (miRNAs) are key post-transcriptional regulators implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the role of miR-25 in the pathogenesis of NSCLC.
- To identify and characterize the interaction between miR-25 and its target gene, RGS3.
- To explore the therapeutic potential of targeting the miR-25/RGS3 axis in NSCLC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to measure miR-25 expression in NSCLC tissues.
- Western blotting to assess RGS3 protein levels.
- Luciferase reporter assays to confirm the binding of miR-25 to the RGS3 3'UTR.
- In vitro cell culture experiments (A549 and H520 cell lines) to evaluate the effects of miR-25 modulation on cell proliferation and apoptosis.
Main Results:
- miR-25 was significantly upregulated in NSCLC tissues compared to normal tissues.
- miR-25 expression was inversely correlated with RGS3 protein levels in NSCLC.
- miR-25 directly targets the 3'UTR of RGS3, leading to its inhibition.
- Overexpression of miR-25 promoted NSCLC cell proliferation and inhibited apoptosis.
- Suppression of miR-25 significantly retarded cell proliferation and induced apoptosis in NSCLC cell lines.
Conclusions:
- The miR-25/RGS3 signaling pathway plays a critical role in the development and progression of NSCLC.
- miR-25 acts as an oncogenic miRNA by downregulating RGS3.
- Targeting the miR-25/RGS3 axis represents a potential therapeutic strategy for NSCLC.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
02:15Experimental RNAi